NO20005950L - Fremgangsmåte for å produsere thy A-stammer fra Vibrio Cholerae, slike stammer og deres anvendelse - Google Patents
Fremgangsmåte for å produsere thy A-stammer fra Vibrio Cholerae, slike stammer og deres anvendelseInfo
- Publication number
- NO20005950L NO20005950L NO20005950A NO20005950A NO20005950L NO 20005950 L NO20005950 L NO 20005950L NO 20005950 A NO20005950 A NO 20005950A NO 20005950 A NO20005950 A NO 20005950A NO 20005950 L NO20005950 L NO 20005950L
- Authority
- NO
- Norway
- Prior art keywords
- thy
- strain
- vibrio cholerae
- sup
- strains
- Prior art date
Links
- 241000607626 Vibrio cholerae Species 0.000 title abstract 6
- 229940118696 vibrio cholerae Drugs 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 abstract 10
- 108090000623 proteins and genes Proteins 0.000 abstract 6
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108020005029 5' Flanking Region Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 210000000349 chromosome Anatomy 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 230000003362 replicative effect Effects 0.000 abstract 1
- 238000002741 site-directed mutagenesis Methods 0.000 abstract 1
- 229940113082 thymine Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1007—Methyltransferases (general) (2.1.1.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9801852A SE9801852D0 (sv) | 1998-05-26 | 1998-05-26 | Method of producing thy A-strains of Vibro cholerae, suck strains and their use |
| PCT/EP1999/003509 WO1999061634A1 (en) | 1998-05-26 | 1999-05-21 | Method of producing thy a-strains of vibrio cholerae, such strains and their use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20005950D0 NO20005950D0 (no) | 2000-11-24 |
| NO20005950L true NO20005950L (no) | 2001-01-25 |
| NO327856B1 NO327856B1 (no) | 2009-10-05 |
Family
ID=20411459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005950A NO327856B1 (no) | 1998-05-26 | 2000-11-24 | Δ thy A-stamme av Vibrio cholerae, vaksine omfattende denne og fremgangsmate for a fremstille et protein i Vibrio cholerae. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7261899B1 (no) |
| EP (1) | EP1080211B1 (no) |
| AT (1) | ATE474055T1 (no) |
| AU (1) | AU4499999A (no) |
| BR (1) | BR9910703B1 (no) |
| CA (1) | CA2329255C (no) |
| CZ (1) | CZ301662B6 (no) |
| DE (1) | DE69942579D1 (no) |
| DK (1) | DK1080211T3 (no) |
| EE (1) | EE05520B1 (no) |
| HK (1) | HK1037206A1 (no) |
| HU (1) | HUP0102310A3 (no) |
| IS (1) | IS2904B (no) |
| NO (1) | NO327856B1 (no) |
| PL (1) | PL197450B1 (no) |
| RU (1) | RU2265657C2 (no) |
| SE (1) | SE9801852D0 (no) |
| WO (1) | WO1999061634A1 (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU22661A1 (es) * | 1997-12-30 | 2001-04-27 | Cnic Ct Nac Investigaciones | Nuevos candidatos vacunales de vibrio cholerae y método de obtención |
| SE9801852D0 (sv) * | 1998-05-26 | 1998-05-26 | Sbl Vaccin Ab | Method of producing thy A-strains of Vibro cholerae, suck strains and their use |
| GB0121998D0 (en) | 2001-09-11 | 2001-10-31 | Acambis Res Ltd | Attenuated bacteria useful in vaccines |
| GB0325494D0 (en) * | 2003-10-31 | 2003-12-03 | Sbl Vaccin Ab | Expression system |
| JP2010088301A (ja) * | 2007-02-01 | 2010-04-22 | Ajinomoto Co Inc | Ｌ−アミノ酸の製造法 |
| EP3503915B1 (en) * | 2016-08-26 | 2024-02-21 | Telesis Bio Inc. | Genetically engineered vibrio natriegens |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5470729A (en) * | 1983-03-04 | 1995-11-28 | University Of Maryland At Baltimore | Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof |
| GB2177097A (en) | 1985-06-18 | 1987-01-14 | Genencor Inc | Stable maintenance of nucleic acid in recombinant cells |
| EP0251579A3 (en) | 1986-06-24 | 1989-03-22 | Enterovax Research Pty. Ltd. | Non-antibiotic marker system |
| US5198343A (en) | 1986-08-05 | 1993-03-30 | Transgene, S.A. | Method for expressing a heterologous protein in a dapD- mutant of E. coli and the strain obtained |
| IE892131A1 (en) * | 1989-06-30 | 1991-01-02 | Univ Cork | Marker genes for genetic manipulation |
| AU683454B2 (en) * | 1993-02-22 | 1997-11-13 | General Hospital Corporation, The | Heterologous antigens in live cell vaccine strains |
| US5434065A (en) * | 1993-05-06 | 1995-07-18 | President And Fellows Of Harvard College | In vivo selection of microbial virulence genes |
| EP0793717B1 (en) * | 1994-10-24 | 2005-01-26 | The Texas A & M University System | Oral immunization with transgenic plants |
| US6251866B1 (en) * | 1997-08-05 | 2001-06-26 | Watson Laboratories, Inc. | Conjugates targeted to the interleukin-2 receptor |
| CU22661A1 (es) * | 1997-12-30 | 2001-04-27 | Cnic Ct Nac Investigaciones | Nuevos candidatos vacunales de vibrio cholerae y método de obtención |
| SE9801852D0 (sv) * | 1998-05-26 | 1998-05-26 | Sbl Vaccin Ab | Method of producing thy A-strains of Vibro cholerae, suck strains and their use |
-
1998
- 1998-05-26 SE SE9801852A patent/SE9801852D0/xx unknown
-
1999
- 1999-05-21 PL PL344483A patent/PL197450B1/pl unknown
- 1999-05-21 EE EEP200000686A patent/EE05520B1/xx not_active IP Right Cessation
- 1999-05-21 RU RU2000132731/13A patent/RU2265657C2/ru not_active IP Right Cessation
- 1999-05-21 HU HU0102310A patent/HUP0102310A3/hu unknown
- 1999-05-21 DE DE69942579T patent/DE69942579D1/de not_active Expired - Lifetime
- 1999-05-21 WO PCT/EP1999/003509 patent/WO1999061634A1/en active Application Filing
- 1999-05-21 CA CA002329255A patent/CA2329255C/en not_active Expired - Fee Related
- 1999-05-21 AU AU44999/99A patent/AU4499999A/en not_active Abandoned
- 1999-05-21 EP EP99927745A patent/EP1080211B1/en not_active Expired - Lifetime
- 1999-05-21 DK DK99927745.2T patent/DK1080211T3/da active
- 1999-05-21 US US09/700,712 patent/US7261899B1/en not_active Expired - Fee Related
- 1999-05-21 BR BRPI9910703-1A patent/BR9910703B1/pt not_active IP Right Cessation
- 1999-05-21 CZ CZ20004354A patent/CZ301662B6/cs not_active IP Right Cessation
- 1999-05-21 AT AT99927745T patent/ATE474055T1/de not_active IP Right Cessation
-
2000
- 2000-11-23 IS IS5724A patent/IS2904B/is unknown
- 2000-11-24 NO NO20005950A patent/NO327856B1/no not_active IP Right Cessation
-
2001
- 2001-09-07 HK HK01106347.6A patent/HK1037206A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO327856B1 (no) | 2009-10-05 |
| IS2904B (is) | 2014-10-15 |
| RU2265657C2 (ru) | 2005-12-10 |
| HUP0102310A3 (en) | 2003-10-28 |
| EP1080211B1 (en) | 2010-07-14 |
| IS5724A (is) | 2000-11-23 |
| SE9801852D0 (sv) | 1998-05-26 |
| PL344483A1 (en) | 2001-11-05 |
| WO1999061634A9 (en) | 2001-12-13 |
| NO20005950D0 (no) | 2000-11-24 |
| AU4499999A (en) | 1999-12-13 |
| CA2329255A1 (en) | 1999-12-02 |
| HUP0102310A2 (hu) | 2001-10-28 |
| PL197450B1 (pl) | 2008-03-31 |
| EE05520B1 (et) | 2012-02-15 |
| EP1080211A1 (en) | 2001-03-07 |
| CA2329255C (en) | 2009-03-10 |
| BR9910703B1 (pt) | 2014-10-29 |
| CZ301662B6 (cs) | 2010-05-19 |
| US7261899B1 (en) | 2007-08-28 |
| DK1080211T3 (da) | 2010-10-18 |
| ATE474055T1 (de) | 2010-07-15 |
| EE200000686A (et) | 2002-04-15 |
| WO1999061634A1 (en) | 1999-12-02 |
| DE69942579D1 (de) | 2010-08-26 |
| BR9910703A (pt) | 2001-01-30 |
| HK1037206A1 (en) | 2002-02-01 |
| CZ20004354A3 (en) | 2001-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kotewicz et al. | Cloning and overexpression of Moloney murine leukemia virus reverse transcriptase in Escherichia coli | |
| JP2005287333A5 (no) | ||
| JPH0724582B2 (ja) | トリプトファン・プロモーター―オペレーターを用いる細菌によるポリペプチドの発現用ベクター | |
| WO1991018101A1 (fr) | Procede de production d'une proteine | |
| NO20005950L (no) | Fremgangsmåte for å produsere thy A-stammer fra Vibrio Cholerae, slike stammer og deres anvendelse | |
| WO2001038484A3 (en) | Moss genes from physcomitrella patens coding proteins involved in the synthesis of polyunsaturated fatty acids and lipids | |
| WO2001044276A3 (en) | Moss genes from physcomitrella patens encoding proteins involved in the synthesis of tocopherols carotenoids and aromatic amino acids | |
| EP0672150B1 (fr) | Levures kluyveromyces modifiees, preparation et utilisation | |
| RU2000132731A (ru) | Способ получения thy a-штаммов vibro cholerae, такие штаммы и их применение | |
| EP0179786A1 (en) | EXPRESSION VECTORS WITH HIGH COPIES. | |
| KR100428998B1 (ko) | 모체 단백질과는 크기와 서열이 다른 단백질의 변이집단을생산하는 방법 | |
| WO2022184287A1 (en) | Fully synthetic, long-chain nucleic acid for vaccine production to protect against coronaviruses | |
| EP4114452A1 (en) | Fully synthetic, long-chain nucleic acid for vaccine production to protect against coronaviruses | |
| TH2022EX (th) | มิวแตนท์ของ วิบริโอ คอเลอรี ที่ไม่มีพิษ | |
| Revel et al. | Production of interferon | |
| JPH08228787A (ja) | 牛成長ホルモンの大量生産方法 | |
| TH3619B (th) | มิวแตนท์ของ วิบริโอ คอเลอรี ที่ไม่มีพิษ | |
| JPH04252193A (ja) | 蛋白質の産生方法 | |
| MXPA00011604A (en) | Method of producing thy | |
| TH2022A (th) | มิวแตนท์ของ วิบริโอ คอเลอรี ที่ไม่มีพิษ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |